Absorbable Vascular (IVC) Filter
Prevention of Pulmonary Embolism (PE)
Feasibility / Early ClinicalActive
Key Facts
Indication
Prevention of Pulmonary Embolism (PE)
Phase
Feasibility / Early Clinical
Status
Active
Company
About Adient Medical
Adient Medical is pioneering a novel class of absorbable medical devices, starting with an absorbable inferior vena cava (IVC) filter. Founded on the premise that implants should perform their function and then vanish, the company's technology aims to address the significant clinical and economic drawbacks of permanent metal IVC filters, which include low retrieval rates and serious long-term complications. The company has demonstrated proof-of-concept and preliminary safety in animal and early human studies, positioning it to potentially disrupt the global IVC filter market. Adient remains a private, pre-revenue entity advancing its lead program toward key regulatory milestones.
View full company profile